Works matching IS 01145916 AND DT 2021 AND VI 44 AND IP 10

Results: 9

A Multidisciplinary Approach in Pharmacovigilance Awareness: ISoP Egypt Chapter's MedSafetyWeek Experience.

Published in:

2021

By:

Rostom, Hadir;
Elhawary, Mohamed A.;
Ali, Islam N.

Publication type:

Editorial

Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy.

Published in:

2021

By:

Day, John W.;
Mendell, Jerry R.;
Mercuri, Eugenio;
Finkel, Richard S.;
Strauss, Kevin A.;
Kleyn, Aaron;
Tauscher-Wisniewski, Sitra;
Tukov, Francis Fonyuy;
Reyna, Sandra P.;
Chand, Deepa H.

Publication type:

journal article

Eritrean Pharmacovigilance System: Key Strategies, Success Stories, Challenges and Lessons Learned.

Published in:

Drug Safety, 2021, v. 44, n. 10, p. 1021, doi. 10.1007/s40264-021-01102-x

By:

Russom, Mulugeta;
Bahta, Iyassu;
Debesai, Merhawi

Publication type:

Article

Smart Safety Surveillance (3S): Multi-Country Experience of Implementing the 3S Concepts and Principles.

Published in:

Drug Safety, 2021, v. 44, n. 10, p. 1085, doi. 10.1007/s40264-021-01100-z

By:

Iessa, Noha;
Macolic Sarinic, Viola;
Ghazaryan, Lilit;
Romanova, Naira;
Alemu, Asnakech;
Rungapiromnan, Watcharee;
Jiamsuchon, Porntip;
Pokhagul, Pattreya;
Castro, Jose Luis;
Macias Saint-Gerons, Diego;
Ghukasyan, Gayane;
Teferi, Mengistab;
Gupta, Madhur;
Pal, Shanthi Narayan

Publication type:

Article

Drug-Related Problems in Hospitalised Patients with Chronic Kidney Disease: A Systematic Review.

Published in:

Drug Safety, 2021, v. 44, n. 10, p. 1041, doi. 10.1007/s40264-021-01099-3

By:

Alruqayb, Wadia S.;
Price, Malcolm J.;
Paudyal, Vibhu;
Cox, Anthony R.

Publication type:

Article

Use of Primary Care Data in Research and Pharmacovigilance: Eight Scenarios Where Prescription Data are Absent.

Published in:

2021

By:

Okoli, Grace N.;
Myles, Puja;
Murray-Thomas, Tarita;
Shepherd, Hilary;
Wong, Ian C. K.;
Edwards, Duncan

Publication type:

journal article

Patient Global Impression of Benefit–Risk (PGI-BR): Incorporating Patients' Views of Clinical Benefit–Risk into Assessment of New Medicines.

Published in:

Drug Safety, 2021, v. 44, n. 10, p. 1059, doi. 10.1007/s40264-021-01079-7

By:

Eek, Daniel;
Halling, Katarina;
Flood, Emuella;
Blowfield, Matthew;
Meyers, Oren;
Venerus, Meredith;
Paty, Jean;
Hermann, Richard

Publication type:

Article

Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK.

Published in:

2021

By:

de Vries, Sieta T.;
Denig, Petra;
Andrić, Adriana;
Dimov Di Giusti, Marina;
Ptaszynska-Neophytou, Alicia;
Härmark, Linda;
Mol, Peter G. M.;
IMI Web-RADR Work Package 3b Consortium and SCOPE Joint Action Work Package 4

Publication type:

journal article

Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing Experience.

Published in:

Drug Safety, 2021, v. 44, n. 10, p. 1099, doi. 10.1007/s40264-021-01097-5

By:

Magalhães, Luís M.;
Costa, Raquel;
Vieira, Mariana;
Moreira, Joana;
Gama, Helena;
Soares-da-Silva, Patrício

Publication type:

Article